Back

Novel oral anticoagulant drugs or oral anticoagulant - What is best for the patient?

19 March 2019 (08:30 - 08:52)
Organised by:
Congress Presentation Part of: Daily business in the pacemaker & arrhythmia clinic Device Therapy, Other EHRA Premium Access EHRA 2019

About the speaker

Photo
Mr Valentino Oriolo

Bristol Royal Infirmary, Bristol (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Atrioventricular block with transcatheter aortic valve implantation is it still a problem
Ms K. Wilson (London, GB)
Slides Video
Presentation thumbnail
CRT in a patient that did benefit and one that did not why?
Mr P. Nolan (Galway, IE)
Slides Video
Presentation thumbnail
Is MRI a risk for the patient?
Mrs L. Hinterbuchner (Linz, AT)
Slides Video

Access the full session

Session thumbnail
Daily business in the pacemaker & arrhythmia clinic

The Event

Event poster

EHRA 2019

19 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
DOACs or warfarin use in morbidly obese patients (BMI > 40 kg/m2) on anticoagulant therapy? : a systematic review and meta-analysis
27 August 2023
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources